We are live on
!
Find out more
CGT
Capital Guardian Trust Portfolio holdings
AUM
$7.42B
1-Year Est. Return
13.6%
This Fund
S&P 500
This Quarter
Est. Return
+1.89%
1 Year Est. Return
+13.6%
3 Year Est. Return
+64.68%
5 Year Est. Return
+85.28%
10 Year Est. Return
–
AUM
$14.4B
AUM Growth
–
Cap. Flow
+$14.5B
Cap. Flow
% of AUM
100.93%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
518
New
517
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$640M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$392M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$361M |
| 4 |
Eaton
ETN
|
+$293M |
| 5 |
Cenovus Energy
CVE
|
+$283M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.68% |
| 2 | Energy | 11.51% |
| 3 | Financials | 11.46% |
| 4 | Technology | 11.02% |
| 5 | Industrials | 10.43% |
Similar funds
WJA
GAM
HIM
DG
KPAG
CAM
CI
LC
Capital Guardian Trust's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital Guardian Trust, which disclosed 518 positions worth $14.4B. Its ten largest holdings account for 23% of the portfolio.
Its largest position is Gilead Sciences: 12,283,597 shares worth $629M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, followed by Energy and Financials.
- Capital Guardian Trust's largest Q2 2013 buy was Gilead Sciences: 12,283,597 shares worth $629M.
- Capital Guardian Trust's ten largest holdings make up 23% of its $14.4B portfolio in Q2 2013.
- Capital Guardian Trust disclosed 518 positions in Q2 2013, its first 13F filing on record.
Based on Capital Guardian Trust's 13F filing for Q2 2013, filed 14 Aug 2013.